SAWC-Spring-2024-Poster_TW

Recent articles

• Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by INVIMA Colombia. 2026-02-22
• The medical device registration application of Bonvadis® for all indications of wounds has been accepted by INVIMA Colombia. 2026-01-31
• Oneness Biotech Highlights Global Strategy at J.P. Morgan Healthcare Conference 2026-01-15
• Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by EDA Egypt. 2026-01-05
• Bonvadis® topical cream received medical device import license for all indications in wounds for India. 2025-12-19
• The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Health Canada. 2025-11-11
• The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Argentina National Administration of Drugs, Foods, and Medical Devices (ANMAT). 2025-10-27